Predicted Tauopathies, Including

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Predicted Tauopathies, Including trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT01056965

Davunetide (AL-108) in Predicted Tauopathies - Pilot Study

The primary objective of the study is to obtain preliminary safety and tolerability data with davunetide (NAP, AL-108) in patients with a tauopathy (frontotempo…

United States12 participantsStarted 2010-01

Treatment: davunetide (AL-108, NAP), Placebo nasal spray